Answers are grounded in this paper and cite their sources.
We describe the development of a molecular assay from publicly available tumor tissue mRNA databases using machine learning and present preliminary evidence of functionality as a diagnostic and monitoring tool for prostate cancer (PCa) in whole blood.
No takes yet. Share an insight, caveat, or question.
Modlin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: